Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers
Mayo study shows the dangers of Enbrel (etanercept) and Remicade This study shows a strong association between the use of TNF-blocking antibodies such as Enbrel (etanercept) or Remicade, and the development of serious infections, such as pneumonia, and cancers.
Patients and health care providers need to be aware of these increased risks when deciding how to treat rheumatoid arthritis, psoriasis, or Crohn’s disease.
Unfortunately, the medical community isn’t aware that there are safe and effective alternatives that tighten control of TNF-alpha production and reduce inflammation without raising the risk of infection and cancer.
It’s clear that conventional medicine is struggling to control chronic inflammation. Remember the cardiovascular problems with the NSAIDs: Vioxx, Celebrex & Bextra.